Crossbow Therapeutics Funding & Investors

Crossbow Therapeutics is a seed-stage, stealth-mode oncology startup company. The company develops antibody engineering for intracellular cancer targets.

Total Amount Raised: $80,000,000

Crossbow Therapeutics Funding Rounds

Series A
$80,000,000
Jul 10, 2023
Series A Investors
MPM Capital
Pfizer Venture Investments
Polaris Partners
Mirae Asset Capital
Eli Lilly
Mirae Asset Venture Investment
Biotechnology Value Fund

Funding info provided by Diffbot.